Junpeng Zhao
Chinese Academy Of Medical Sciences And Peking Union Medical College
Nanjing, 210042, China
Nanjing, 210042, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Structure characterization and repair of UVB-induced skin inflammation of rhamnomannan derived from Roseomonas mucosa DL-1.
Journal: International journal of biological macromolecules
Published: April 10, 2025
Microbiota-Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 18, 2024
T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE.
Journal: Lupus
Published: January 30, 2024
Blockade of OX40/OX40L signaling using anti-OX40L alleviates murine lupus nephritis.
Journal: European journal of immunology
Published: November 24, 2023
2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus.
Journal: Signal transduction and targeted therapy
Published: November 24, 2023
CYSLTR1 antagonist inhibits Th17 cell differentiation by regulating the NF-κB signaling for the treatment of psoriasis.
Journal: International journal of biological sciences
Published: November 23, 2023
TIGIT-Fc fusion protein alleviates murine lupus nephritis through the regulation of SPI-B-PAX5-XBP1 axis-mediated B-cell differentiation.
Journal: Journal of autoimmunity
Published: April 30, 2023
TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer.
Journal: International immunopharmacology
Published: April 02, 2023
Animal models of systemic lupus erythematosus and their applications in drug discovery.
Journal: Expert opinion on drug discovery
Published: March 15, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026